Paranthaman Senthamarai Kannan

FDA investigator

Appears on 4 documents from 2024 to 2026, most often at sites in India. Most often cites stability testing (21 CFR 211.166).

4
Documents on file
5.5
Observations per 483
2024
First seen
2026
Most recent

What they cite most

From 22 observations

Activity by year

2024: 2, 2026: 2

Where

India 1 · Kentucky 1 · Malaysia 1

Is Paranthaman Senthamarai Kannan coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 Almon Healthcare Private LimitedFeb 13, 2026
483 SNJ Labs Private Ltd.Feb 6, 2026 · Rajkot, India
483 Richie Pharmacal Company, IncDec 12, 2024 · Glasgow, Kentucky
483 Form 483 · FEI 3011248248Sep 27, 2024 · Iskander Puteri, Malaysia

About this profile

What does Paranthaman Senthamarai Kannan inspect?

Paranthaman Senthamarai Kannan appears on 4 documents on file covering 4 sites, most often in India.

What do they cite most often?

21 CFR 211.166 (stability testing), followed by 21 CFR 211.67 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Paranthaman Senthamarai Kannan is dated Feb 13, 2026.